COMMUNIQUÉS West-GlobeNewswire

Kaleido Biosciences Appoints Jerald Korn as General Counsel and Corporate Secretary
22/07/2019
LEXINGTON, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the potential of the microbiome organ to [...]
Medtronic Partners with Viz.ai to Accelerate Adoption of New Artificial Intelligence Software in U.S. Stroke Centers
22/07/2019
Technology Has the Potential to Save Crucial Time and Increase Access to Lifesaving Stroke Treatments DUBLIN and SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical [...]
R1 RCM to Release Second Quarter 2019 Results on August 6
22/07/2019
CHICAGO, July 22, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]
Fulgent Genetics to Announce Second Quarter 2019 Financial Results on Monday August 5, 2019
22/07/2019
TEMPLE CITY, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2019 financial results after the [...]
VBL Therapeutics Announces Modiin Production Facility Received a GMP Compliance Certificate Following EU QP Audit
22/07/2019
TEL AVIV, Israel, July 22, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Quotient Limited to Report First Quarter 2020 Financial Results and Host Conference Call
22/07/2019
JERSEY, Channel Islands, July 22, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2019 [...]
headversity Raises $1 Million in Seed Funding
22/07/2019
Calgary Resilience Training Company Gets Backing from Angel Investors CALGARY, July 22, 2019 (GLOBE NEWSWIRE) -- headversity , a workplace resilience training app, announced that it has raised a $1 million seed-stage [...]
Konica Minolta and Shimadzu Join Forces to Bring Dynamic Digital Radiography to the US Digital Radiography Market
22/07/2019
WAYNE, N.J. and TORRANCE, Calif., July 22, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., a leader in medical imaging systems and healthcare IT, along with Shimadzu Medical Systems USA today [...]
Daré Announces Presentation of Two Posters at the 2019 Controlled Release Society Annual Meeting & Exposition
22/07/2019
DARE-HRT1 is a potential treatment of menopause-related symptoms DARE-FRT1 is a potential pregnancy maintenance therapy SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women [...]
Sun BioPharma, Inc. Provides an Update on Ongoing Front-line Pancreatic Cancer Clinical Trial
22/07/2019
Preliminary Efficacy Signals Seen with SBP-101 Administered in Combination with Gemcitabine and Nab-paclitaxel DSMB Approves Enrollment of 3 rd and Final Cohort MINNEAPOLIS, July 22, 2019 (GLOBE NEWSWIRE) -- Sun [...]
Share buy-back week 29/2019
22/07/2019
Announcement 22 July 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
Vystar Enters Definitive Agreement to Acquire Rotmans Furniture – Largest Independent Furniture Retailer in Northeast
22/07/2019
Rotmans Furniture expected to significantly increase Vystar revenue Provides Vystar with sales, warehousing and distribution infrastructure Enables Rotmans Furniture to access the capital markets for future growth and [...]
Global Cannabis Corp & Partner SLANG Worldwide Receive Greek Medical Cannabis Cultivation, Processing and Manufacturing License
22/07/2019
TORONTO and ATHENS, Greece, July 22, 2019 (GLOBE NEWSWIRE) -- Global Cannabis Corp. (“ GCC ” or the “ Company ”) and its partner SLANG Worldwide Inc. ( CNSX: SLNG ), (Frankfurt: 84S), (" SLANG ") are pleased to announce [...]
Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People Officer
22/07/2019
CRESTWOOD, Ky. and WALTHAM, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Cyclacel Pharmaceuticals Announces First Patient Treated in a Phase 1/2 Study of Sapacitabine and Venetoclax in Relapsed or Refractory AML or MDS Patients
22/07/2019
BERKELEY HEIGHTS, N.J., July 22, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis
22/07/2019
SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced dosing of the first patient in the ZEPHYRUS Phase 3 clinical study of pamrevlumab in patients with idiopathic pulmonary [...]
MediWound Launches EscharEx® U.S. Clinical Development Program
22/07/2019
Company’s primary focus turns to EscharEx following its successful collaboration for NexoBrid Company to initiate an adaptive comprehensive adequately controlled study in 4Q 2019 Company to host Analyst Day today, July [...]
Cara Therapeutics Announces No Modifications in Trial Size for Phase 2 Trial of Oral KORSUVA™ in Chronic Kidney Disease Patients with Pruritus after Completion of Interim Statistical Assessment
22/07/2019
- Study now fully enrolled; topline data expected in 4Q 2019 - STAMFORD, Conn., July 22, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and [...]
Achillion’s ACH-5228 Achieves Positive Results in Phase 1 Multiple Ascending Dose Study in Healthy Volunteers
22/07/2019
ACH-5228 delivers near complete and sustained inhibition of the complement alternative pathway Twice-daily oral administration to move forward in Phase 2 trials Investigational New Drug (IND) application to be submitted [...]

Pages